| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
1 company
Greenberg Robert is a corporate insider. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $4.7M at current prices.
Greenberg Robert's largest disclosed position is in LIXT, worth about $4.7M. Net of sales, the recent Form 4 record there shows accumulation of 52,632 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2020 | LIXT Lixte Biotechnology Holdings, Inc. | - | Buy | 52,632 | $4.75 | $250,002.00 | +5.6% |